Found: 9
Select item for more details and to access through your institution.
Fcγ-receptor IIIA polymorphism p.158F has no negative predictive impact on rituximab therapy with and without sequential chemotherapy in CD20-positive posttransplant lymphoproliferative disorder.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Fcγ-Receptor IIIA Polymorphism p.158F Has No Negative Predictive Impact on Rituximab Therapy with and without Sequential Chemotherapy in CD20-Positive Posttransplant Lymphoproliferative Disorder.
- Published in:
- Journal of Immunology Research, 2014, p. 1, doi. 10.1155/2014/264723
- By:
- Publication type:
- Article
Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 10, p. 1717, doi. 10.1007/s00277-014-2103-3
- By:
- Publication type:
- Article
Erratum to: Maintenance with rituximab is safe and not associated with severe or uncommon infections in patients with follicular lymphoma: results from the phase IIIb MAXIMA study.
- Published in:
- 2014
- By:
- Publication type:
- Erratum
Rituximab in the management of post-transplantation lymphoproliferative disorder after solid organ transplantation: proceed with caution.
- Published in:
- Annals of Hematology, 2007, v. 86, n. 8, p. 599, doi. 10.1007/s00277-007-0298-2
- By:
- Publication type:
- Article
Epstein–Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
- Published in:
- Annals of Hematology, 2006, v. 85, n. 7, p. 478, doi. 10.1007/s00277-006-0109-1
- By:
- Publication type:
- Article
Burkitt post-transplantation lymphoma in adult solid organ transplant recipients.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 19, p. 4715, doi. 10.1002/cncr.27482
- By:
- Publication type:
- Article
Salvage chemotherapy for refractory or relapsed post-transplant lymphoproliferative disorder in patients after solid organ transplantation with a combination of carboplatin and etoposide.
- Published in:
- British Journal of Haematology, 2003, v. 123, n. 5, p. 830, doi. 10.1046/j.1365-2141.2003.04705.x
- By:
- Publication type:
- Article
Identification of early antigen BZLF1/ZEBRA protein of Epstein–Barr virus can predict the effectiveness of antiviral treatment in patients with post-transplant lymphoproliferative disease.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 4, p. 1120, doi. 10.1046/j.1365-2141.2002.03764.x
- By:
- Publication type:
- Article